
Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: To use or not to use?
Keywords: بقای کل; BCG; Bacillus Calmette-Guérin; BMDC; bone marrow-derived dendritic cell; CTA; cancer/testis antigen; CTL; cytotoxic T lymphocyte; CTLA-4; cytotoxic T lymphocyte antigen-4; DC; dendritic cell; DNA; deoxyribonucleic acid; DTH; delayed-type hypersensitivity